88
Participants
Start Date
February 28, 2010
Primary Completion Date
April 30, 2011
Study Completion Date
April 30, 2011
Formoterol/Budesonide
formoterol will be administered at the 12 µg dosage, twice a day, and budesonide will be administered at the 200 µg dose, also twice a day for 12 weeks.
Foraseq
formoterol will be administered at the 12 µg dosage, twice a day, and budesonide will be administered at the 200 µg dose, also twice a day for 12 weeks.
Centro de Pesquisa Clínica Stelmach, São Paulo
Lead Sponsor
Eurofarma Laboratorios S.A.
INDUSTRY